CONCORD DRUGS
Back to Cashflow Statement
|
CONCORD DRUGS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-1.43 Cr | ₹0.28 Cr | ₹0.62 Cr | ₹1.68 Cr |
What is the latest Cash Flow from Financing Activities ratio of CONCORD DRUGS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-1.43 Cr |
| Mar2024 | ₹0.28 Cr |
| Mar2023 | ₹0.62 Cr |
| Mar2022 | ₹1.68 Cr |
How is Cash Flow from Financing Activities of CONCORD DRUGS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-1.43 Cr | Negative | |
| Mar2024 | ₹0.28 Cr | -54.65 | |
| Mar2023 | ₹0.62 Cr | -62.84 | |
| Mar2022 | ₹1.68 Cr | - | |
Compare Cash Flow from Financing Activities of peers of CONCORD DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD DRUGS | ₹93.7 Cr | -2.4% | -1% | -16.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,944.0 Cr | -2% | 6% | 9.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹294,962.0 Cr | -4% | 22.9% | 75.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹178,391.0 Cr | -1.8% | 1.8% | 21.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,267.0 Cr | -0.4% | 13.1% | 13.7% | Stock Analytics | |
| CIPLA | ₹112,620.0 Cr | -0.9% | 4.5% | -8% | Stock Analytics | |
CONCORD DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD DRUGS | -2.4% |
-1% |
-16.2% |
| SENSEX | 1.4% |
12.8% |
-1.7% |
You may also like the below Video Courses